To include your compound in the COVID-19 Resource Center, submit it here.

Biogen Corp., Schering-Plough sales and marketing update

Bear, Stearns analyst David Molowa said Intron A royalties will continue to

Read the full 123 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE